Ilya Petrou, M.D.
Research sheds light on pathophysiology of acne, rosacea
Research sheds light on pathophysiology of acne, rosacea
Although the symptoms of acne and rosacea are well established, clear and definitive etiologies of these conditions have largely been unknown. Recent research, however, has shed new light into the pathophysiology of these conditions, paving the way for more targeted therapies.
How to improve prescription adherence
Lack of patient adherence to prescribed therapies remains a central issue in dermatology and, according to one expert, a multifaceted strategy can improve compliance, leading to improved treatment outcomes.
Guidelines clarify controversies surrounding vitamin D
Vitamin D has been in and out of favor with physicians and their patients over the years. Even today, the controversies over the embattled vitamin still continue regarding its safe and beneficial daily allowance. According to the recent research, however, and guidelines from the Institute of Medicine (IOM), the majority of Americans are taking enough vitamin D.
Advanced genetic testing paves way for personalized medicine
New genetic testing methods may not only help identify the potential risk for individuals to develop certain diseases but may also open the door for more targeted therapies and management strategies, which could be of particular benefit in higher risk patient populations.
Alternative medicine can help where traditional therapies fail
The field of alternative medicine is increasing in popularity among dermatologists in the United States, particularly among their patients. Though conventional treatment approaches can be effective in quelling the symptoms associated with atopic dermatitis and other cutaneous diseases and conditions, “natural” remedies can also be of significant value in carefully selected patients.
Finding cause of chronic pruritus helps to narrow down treatment strategies
An accurate assessment of the potential cause of chronic pruritus, coupled by a careful selection of current standard treatments as well as new and emerging therapies, can be instrumental in helping to quell the symptoms of this sometimes severely debilitating condition.
Chemopreventive agents being explored could protect skin from developing cancer
Efforts to prevent and chemoprevent melanoma are ongoing, and though much still needs to be done, one expert says some inroads are being made that may impact mortality, morbidity and quality of life.
Dermal gamma delta T cells play role in pathogenesis of psoriasis
Researchers have recently identified gamma delta T cells as having an important role in the pathogenesis of psoriasis. This considerable breakthrough in the pathogenesis of the disease could potentially have far-reaching implications in terms of more targeted therapies for psoriasis.
Advances in psoriasis therapy research improve safety, efficacy of treatment
The systemic treatments of psoriasis are rapidly evolving as pharmaceutical companies continue their research to discover safer and more tolerable systemic medications for psoriasis patients.
Many potential indications for botulinum toxin formulations have yet to be realized
The emergence of new formulations of botulinum toxin and other neuromodulators in the pipeline awaiting approval by the Food and Drug Administration signal a need for clinicians to stay abreast of the various uses and potential adverse events.


View Results